According to a 13F filing submitted to the U.S. Securities and Exchange Commission (SEC), Wells Fargo (WFC.US) disclosed its third-quarter holdings report for the period ended September 30, 2026.
As of September 30, 2026, Wells Fargo's total holdings market value stood at approximately $640 billion, up from about $620 billion in the prior quarter, a quarter-over-quarter increase of 3.23%.
Based on data provider statistics, during the quarter Wells Fargo initiated 551 new positions, increased holdings in 2,046 targets, fully exited 514 targets, and reduced holdings in 3,871 targets. The top ten holdings accounted for 22.12% of the portfolio, with a turnover rate of 13.94%, and the top 20 positions were held for an average of about 21.1 quarters. This filing reflects a relatively high concentration, meaning market value changes are largely driven by price movements in core holdings, so the roughly $20 billion increase in market value should not be directly interpreted as an equivalent scale of capital inflow.
Top Five Holdings
The largest position was British pharmaceutical giant AstraZeneca PLC (AZN.US), with a market value of approximately $26.41 billion, representing 4.10% of the portfolio — a sharp jump from 0.05% in the prior quarter. The weight rose by 4.05 percentage points, making it the target with the largest weight increase during the quarter.
Apple (AAPL.US) ranked second, with approximately 59.77 million shares held and a market value of about $19.90 billion, accounting for 3.09% of the portfolio. The share count decreased by 0.24% from the previous quarter.
Microsoft (MSFT.US) ranked third, with approximately 34.41 million shares held and a market value of about $17.65 billion, representing 2.74% of the portfolio. The share count increased by 2.96% from the prior quarter.
The iShares Core S&P 500 ETF (IVV.US) ranked fourth, with approximately 20.27 million shares held and a market value of about $15.53 billion, accounting for 2.41% of the portfolio. The share count decreased by 0.72% from the previous quarter.
AI chip leader Nvidia (NVDA.US) ranked fifth, with approximately 65.05 million shares held and a market value of about $14.86 billion, representing 2.31% of the portfolio. The share count increased by 10.51% from the prior quarter.
The other top holdings ranked sixth through tenth were: the S&P Total Market ETF (ITOT.US), Google parent Alphabet (GOOGL.US), the MSCI EAFE ETF (IEFA.US), the SPDR S&P 500 ETF (SPY.US), and semiconductor and infrastructure software company Broadcom (AVGO.US), with market values of approximately $11.02 billion, $10.31 billion, $9.28 billion, $8.77 billion, and $8.67 billion, respectively.
Position Adjustments
In terms of changes in portfolio weight, Wells Fargo's top five buys were: AstraZeneca PLC (AZN.US), Microsoft (MSFT.US), Nvidia (NVDA.US), Nasdaq 100 ETF call options (QQQ.US), and Russell 2000 ETF put options (IWM.US), with weights rising by 4.05, 0.72, 0.40, 0.36, and 0.30 percentage points, respectively. Among these, Nvidia (NVDA.US) saw its share count increase from approximately 58.86 million to about 65.05 million, a gain of 10.51%; Microsoft (MSFT.US) rose from approximately 33.45 million to about 34.41 million shares, a gain of 2.96%.
The top five sells were: Visa (V.US), SPDR S&P 500 ETF put options (SPY.US), SanDisk (SNDK.US), Vanguard Mid-Cap ETF (VO.US), and iShares Russell Mid-Cap ETF (IWR.US). Among these, the Vanguard Mid-Cap ETF (VO.US) ranked 13th in the portfolio, with its share count falling 10.45% from the prior quarter — the largest reduction among the top 20 holdings.
New Positions
In terms of new positions, Wells Fargo initiated 551 new targets during the quarter, the largest of which was call options on pharmaceutical company Moderna (MRNA.US), with a reported value of approximately $462 million, accounting for 0.07% of the portfolio. Other larger new positions included: Micron Technology (MU.US) put options at approximately $155 million, data monitoring company Datadog (DDOG.US) put options at approximately $126 million, Datadog call options at approximately $107 million, Consumer Discretionary Select Sector ETF (XLY.US) call options at approximately $71 million, and used-car e-commerce platform Carvana (CVNA.US) call options at approximately $59 million. It also initiated put and call options on SanDisk (SNDK.US), call options on TSMC (TSM.US), call options on the gold ETF (GLD.US), put options on the crude oil ETF (USO.US), and put options on semiconductor company Semtech (SMTC.US), among others.
Exited Positions
In terms of exits, Wells Fargo closed out 514 targets during the quarter. Among the more well-known names were put options on TSMC (TSM.US), gaming company Electronic Arts (EA.US), apartment REIT AvalonBay (AVB.US), put options on solar module maker First Solar (FSLR.US), and put options on telecom operator Charter Communications (CHTR.US). It also exited put options on Nebius Group (NBIS.US), healthcare group Select Medical (SEM.US), call options on NRG Energy (NRG.US), and call options on News Corp Class A (NWSA.US), among others.
Wells Fargo's options holdings were active this quarter. Among the top 20 holdings, Nasdaq 100 ETF call options (QQQ.US) had a reported value of approximately $6.06 billion, accounting for 0.94% of the portfolio, while Russell 2000 ETF put options (IWM.US) had a reported value of approximately $5.77 billion, accounting for 0.90%. Their weights rose by 0.36 and 0.30 percentage points, respectively, from the prior quarter, and both entered the quarter's top five buys.
Summary
Overall, Wells Fargo's total holdings market value continued to expand in the third quarter, with the top ten concentration maintained at 22.12%. AstraZeneca PLC (AZN.US) saw its weight surge by 4.05 percentage points in a single quarter and replaced Apple (AAPL.US) as the largest position — the most notable change this quarter. New positions and exits were both dominated by options.
Comments